Back
BridgeBio Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
BBIO
BridgeBio Pharma
Last Price:
$33.70
Seasonality Move:
35.26%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.11 | Sell |
20-day SMA: | 35.66 | Sell |
50-day SMA: | 34.44 | Sell |
200-day SMA: | 29.68 | Buy |
8-day EMA: | 34.31 | Sell |
20-day EMA: | 34.88 | Sell |
50-day EMA: | 34.48 | Sell |
200-day EMA: | 31.24 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 44.09 | Sell |
Chaikin Money Flow: | 1558967 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.67 - 37.01) | Sell |
Bollinger Bands (100): | (30.66 - 36.38) | Buy |
BridgeBio Pharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.69 while BBIO 8-day simple moving average is 34.11, which is a Sell signal.
-
The stock price of BBIO is 33.69 while BridgeBio Pharma 20-day SMA is 35.66, which makes it a Sell.
-
BridgeBio Pharma 50-day simple moving average is 34.44 while BBIO share price is 33.69, making it a Sell technically.
-
BBIO stock price is 33.69 and BridgeBio Pharma 200-day simple moving average is 29.68, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $33.69. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
6.4B
Price in USD:
33.69
Share Volume:
2.4M
BridgeBio Pharma 52-Week Range
52-Week High:
39.54
52-Week Low:
21.62
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 33.69 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.69 while BBIO 8-day exponential moving average is 34.31, which is a Sell signal.
-
The stock price of BBIO is 33.69 while BridgeBio Pharma 20-day EMA is 34.88, which makes it a Sell.
-
BridgeBio Pharma 50-day exponential moving average is 34.48 while BBIO share price is 33.69, making it a Sell technically.
-
BBIO stock price is 33.69 and BridgeBio Pharma 200-day simple moving average is 31.24, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.22 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting BridgeBio Pharma is a Sell
-
BridgeBio Pharma Relative Strength Index (RSI) is 44.09, which suggest BridgeBio Pharma is oversold
-
The Bollinger Bands (25) for BridgeBio Pharma is (33.67 - 37.01), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (30.66 - 36.38), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.